• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Ischemic Stroke Surgery Market Share

    ID: MRFR/HC/9493-CR
    136 Pages
    Rahul Gotadki
    October 2022

    Ischemic Stroke Surgery Market Research Report Information by Type of Surgery (Thrombectomy, Revascularization Surgery, Carotid Endarterectomy and Angioplasty), by Product Type (Catheter, Aspiration System, Guidewire, Microcatheter and Others), by End User (Hospitals and Clinics, Ambulatory Surgical Centers and Others) Region (North America, Europe, Asia-Pacific, and Rest of the World)—Forecast...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Ischemic Stroke Surgery Market Infographic
    Purchase Options

    Market Share

    Ischemic Stroke Surgery Market Share Analysis

    The Ischemic Stroke Surgery Market presents a myriad of opportunities for growth and innovation as advancements in medical technology and research continue to unfold. This dynamic and rapidly evolving sector holds promise for various stakeholders, including healthcare providers, medical device manufacturers, pharmaceutical companies, and investors. Here are 800 simple words highlighting the opportunities in the Ischemic Stroke Surgery Market:

    Introduction: The Ischemic Stroke Surgery Market is witnessing a surge in opportunities driven by a combination of technological advancements, increasing prevalence of ischemic strokes, and a growing aging population. Ischemic strokes account for a significant portion of all stroke cases, making it a focal point for healthcare interventions and innovations. As the global healthcare landscape continues to prioritize stroke management, the market for Ischemic Stroke Surgery is poised for substantial growth.

    Technological Advancements: One of the primary drivers of opportunities in the Ischemic Stroke Surgery Market is the continuous evolution of surgical technologies. Minimally invasive procedures, robotic-assisted surgeries, and advanced imaging techniques are transforming the landscape of ischemic stroke interventions. These innovations not only enhance the precision of surgeries but also contribute to reduced recovery times and improved patient outcomes. Medical device manufacturers have a ripe opportunity to invest in research and development to create cutting-edge tools that can further streamline ischemic stroke surgeries.

    Telemedicine and Remote Monitoring: The integration of telemedicine and remote monitoring in ischemic stroke care presents another avenue of opportunity. With the advent of digital health solutions, healthcare providers can remotely monitor post-surgery recovery, track patient progress, and intervene promptly in case of complications. This not only enhances patient care but also reduces the burden on healthcare facilities, opening doors for companies specializing in telehealth solutions to contribute to the Ischemic Stroke Surgery Market.

    Personalized Medicine: The move towards personalized medicine is gaining momentum in the Ischemic Stroke Surgery Market. Tailoring treatment plans based on individual patient characteristics, genetics, and other factors can significantly improve the efficacy of interventions. Pharmaceutical companies have the opportunity to explore and develop targeted therapies that address specific aspects of ischemic strokes, potentially revolutionizing treatment approaches and outcomes.

    Global Collaborations and Partnerships: Global collaborations and partnerships offer a promising avenue for growth in the Ischemic Stroke Surgery Market. Collaborations between healthcare institutions, research organizations, and industry players can facilitate knowledge exchange, joint research initiatives, and the development of innovative solutions. This collaborative approach fosters a synergistic environment where collective efforts can address the complex challenges associated with ischemic stroke surgery.

    Preventive Interventions: Opportunities also lie in the development of preventive interventions for ischemic strokes. Identifying individuals at high risk and implementing preemptive measures can significantly reduce the incidence of strokes. This opens the door for pharmaceutical companies and researchers to explore novel medications, lifestyle interventions, and other preventive strategies that can contribute to a holistic approach in managing ischemic stroke risk.

    Patient Education and Awareness: An often-overlooked opportunity in the Ischemic Stroke Surgery Market is patient education and awareness. Empowering individuals with knowledge about risk factors, symptoms, and preventive measures can lead to early detection and intervention. Companies specializing in healthcare communication, digital marketing, and educational materials have the chance to play a vital role in enhancing public awareness about ischemic strokes and available surgical interventions.

    Investment Opportunities: Investors keen on the healthcare sector can find lucrative opportunities in the Ischemic Stroke Surgery Market. As the demand for advanced surgical interventions rises, funding innovative startups, supporting research endeavors, and investing in established companies within the ischemic stroke space can yield substantial returns. The market's dynamic nature and potential for groundbreaking discoveries make it an attractive proposition for investors seeking growth opportunities.

    Conclusion: The Ischemic Stroke Surgery Market presents a landscape rich with opportunities for those involved in healthcare, technology, and research. The convergence of technological advancements, personalized medicine, and a global collaborative approach creates a fertile ground for transformative developments in ischemic stroke interventions. Embracing these opportunities not only holds the potential for economic growth but, more importantly, contributes to advancing the quality of care for individuals at risk of or affected by ischemic strokes.

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    How Big is the Ischemic Stroke Surgery market?

    The Ischemic Stroke Surgery Market is anticipated to reach USD 6.77 billion by 2035 and register a CAGR of 6.52% during the forecast period of 2024 to 2032.

    Who are the key competitors in the market of Ischemic Stroke Surgery?

    Stryker (US), Medtronic PLC (Ireland), Johnson & Johnson Services Inc. (US), Boston Scientific Corporation (US), Penumbra, Inc. (US), Abbott Laboratories (US), Koninklijke Philips N.V. (Netherlands), Imperative Care (US), Abbott Laboratories (US), and Phenox GmbH (Germany) are the key players in the market of Ischemic Stroke Surgery

    Which region is predicted to have the largest market share of Ischemic Stroke Surgery

    North America is predicted to lead the market of Ischemic Stroke Surgery

    What are the key factors driving the market of Ischemic Stroke Surgery?

    Rise in physical inactivity and sedentary lifestyles and Adoption and launch of technologically advanced products are driving the market growth

    Which factors may act as market deterrents Ischemic Stroke Surgery?

    Lack of medical facilities and Shortage of skilled professionals are the market deterrents.

    Market Summary

    As per Market Research Future Analysis, the Global Ischemic Stroke Surgery Market was valued at USD 3.84 Billion in 2023 and is projected to reach USD 6.77 Billion by 2032, growing at a CAGR of 6.52% from 2024 to 2032. The market is driven by increasing physical inactivity, the launch of advanced products, and a rising demand for minimally invasive procedures. However, challenges such as a lack of medical facilities in developing countries and a shortage of skilled professionals may hinder growth. The COVID-19 pandemic moderately disrupted production and revenue in 2020, but recovery was noted in 2021 as supply chains were restored.

    Key Market Trends & Highlights

    Key trends influencing the ischemic stroke surgery market include technological advancements and demographic shifts.

    • Market Size in 2023: USD 3.84 Billion
    • Projected Market Size by 2032: USD 6.77 Billion
    • CAGR from 2024 to 2032: 6.52%
    • Major Growth Drivers: Increase in sedentary lifestyles and demand for minimally invasive procedures

    Market Size & Forecast

    2023 Market Size USD 3.84 Billion
    2024 Projected Market Size USD 4.08 Billion
    2032 Projected Market Size USD 6.77 Billion
    CAGR (2024-2032) 6.52%

    Major Players

    Stryker (US), Medtronic Plc (Ireland), Johnson & Johnson Services Inc. (US), Boston Scientific Corporation (US), Penumbra, Inc. (US), Abbott Laboratories (US), Koninklijke Philips N.V. (Netherlands), Imperative Care (US), Phenox GmbH (Germany)

    Market Trends

    The Global Ischemic Stroke Surgery Market is poised for growth as advancements in surgical techniques and technologies enhance patient outcomes and recovery times.

    U.S. National Institutes of Health (NIH)

    Ischemic Stroke Surgery Market Market Drivers

    Aging Population

    The aging global population is a critical driver of the Global Ischemic Stroke Surgery Market Industry. As individuals age, the risk of ischemic stroke increases significantly due to factors such as hypertension, diabetes, and other comorbidities. This demographic shift necessitates a robust healthcare response, particularly in surgical interventions for stroke management. With a larger segment of the population requiring surgical treatment, the market is poised for growth. The projected increase in market size from 4.08 USD Billion in 2024 to 8.18 USD Billion by 2035 underscores the urgency of addressing the needs of this aging demographic.

    Growing Awareness and Education

    There is a notable increase in awareness and education regarding stroke symptoms and the importance of timely intervention, which is positively impacting the Global Ischemic Stroke Surgery Market Industry. Public health campaigns and educational programs are encouraging individuals to seek immediate medical attention when experiencing stroke symptoms. This heightened awareness leads to earlier diagnosis and treatment, which is crucial for successful surgical outcomes. As more patients become informed about their options, the demand for ischemic stroke surgeries is likely to rise, contributing to the overall growth of the market.

    Increasing Healthcare Expenditure

    The rise in global healthcare expenditure is a significant factor influencing the Global Ischemic Stroke Surgery Market Industry. Governments and private sectors are investing more in healthcare infrastructure, leading to enhanced access to surgical interventions for ischemic stroke patients. This increased funding allows for the procurement of advanced surgical equipment and training for healthcare professionals. As healthcare systems prioritize stroke management, the market is expected to benefit from improved facilities and resources. This trend aligns with the projected growth of the market, reaching 4.08 USD Billion in 2024 and continuing to expand towards 8.18 USD Billion by 2035.

    Rising Incidence of Ischemic Stroke

    The increasing prevalence of ischemic stroke globally is a primary driver for the Global Ischemic Stroke Surgery Market Industry. According to health statistics, ischemic strokes account for approximately 87 percent of all strokes, leading to a growing demand for surgical interventions. As the global population ages, the incidence of ischemic strokes is projected to rise, necessitating advancements in surgical techniques and technologies. This trend is expected to contribute significantly to the market's growth, with the industry projected to reach 4.08 USD Billion in 2024 and potentially 8.18 USD Billion by 2035, reflecting a compound annual growth rate of 6.53% from 2025 to 2035.

    Technological Advancements in Surgical Procedures

    Innovations in surgical techniques and technologies are transforming the Global Ischemic Stroke Surgery Market Industry. Minimally invasive procedures, such as endovascular thrombectomy, have shown promising results in improving patient outcomes. These advancements not only enhance the efficacy of surgeries but also reduce recovery times, thereby increasing patient throughput. The integration of robotic-assisted surgery and advanced imaging techniques further supports the precision of interventions. As hospitals and surgical centers adopt these technologies, the market is likely to expand, driven by the demand for improved surgical outcomes and patient satisfaction.

    Market Segment Insights

    Regional Insights

    Key Companies in the Ischemic Stroke Surgery Market market include

    Industry Developments

      • In February 2022, Imperative Care launched the Zoom POD for stroke therapy. The Zoom POD is the world's first and only sterile field clot filtration device, allowing for speedier clot collection during essential mechanical thrombectomy treatments for patients suffering from ischemic stroke.
      • In February 2022, Johnson & Johnson Services, Inc. launched EMBOGUAR, a next-generation balloon guide catheter for use in endovascular therapies, notably those for patients suffering from acute ischemic stroke.
      • In October 2021, Phenox GmbH launched the pRESET 6-50 mechanical thrombectomy device to broaden its technological range for acute ischemic stroke across the globe.
      • In September 2021, Abbott acquired Walk Vascular, LLC (US), a medical device company with a minimally invasive mechanical aspiration system designed to remove peripheral blood clots. This acquisition will help to expand the company's peripheral vascular offerings.
      • In February 2021, Phenox GmbH expands with the creation of a new office in the UK to increase its presence in important markets around Europe.

    Future Outlook

    Ischemic Stroke Surgery Market Future Outlook

    The Ischemic Stroke Surgery Market is projected to grow at a 6.53% CAGR from 2024 to 2035, driven by advancements in surgical techniques, increasing prevalence of ischemic strokes, and enhanced healthcare infrastructure.

    New opportunities lie in:

    • Invest in AI-driven surgical tools to improve precision and outcomes.
    • Develop minimally invasive techniques to reduce recovery times and costs.
    • Expand telemedicine services for pre- and post-operative care to enhance patient access.

    By 2035, the Ischemic Stroke Surgery Market is expected to be robust, reflecting significant advancements and increased accessibility.

    Market Segmentation

    Report Overview

    North America
    • US
    • Canada

    Report Scope

    Report Attribute/Metric Details
    Market Size 2023 3.84 (USD Billion)
    Market Size 2024 4.08 (USD Billion)
    Market Size 2032 6.77 (USD Billion)
    Compound Annual Growth Rate (CAGR) 6.52 % (2024 - 2032)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2023
    Market Forecast Period 2024 - 2032
    Historical Data 2019 - 2023
      Geographies Covered   North America, Europe, Asia-Pacific, Rest of the World
      Key Vendors   Stryker (US), Medtronic PLC (Ireland), Johnson & Johnson Services Inc. (US), Boston Scientific Corporation (US), Penumbra, Inc. (US), Abbott Laboratories (US), Koninklijke Philips N.V. (Netherlands), Imperative Care (US), Abbott Laboratories (US), and Phenox GmbH (Germany)
      Key Market Opportunities  R&D activities and investments
      Key Market Drivers  Rise in physical inactivity and sedentary lifestyles • Adoption and launch of technologically advanced products Rising demand for minimally invasive procedures

    FAQs

    How Big is the Ischemic Stroke Surgery market?

    The Ischemic Stroke Surgery Market is anticipated to reach USD 6.77 billion by 2035 and register a CAGR of 6.52% during the forecast period of 2024 to 2032.

    Who are the key competitors in the market of Ischemic Stroke Surgery?

    Stryker (US), Medtronic PLC (Ireland), Johnson & Johnson Services Inc. (US), Boston Scientific Corporation (US), Penumbra, Inc. (US), Abbott Laboratories (US), Koninklijke Philips N.V. (Netherlands), Imperative Care (US), Abbott Laboratories (US), and Phenox GmbH (Germany) are the key players in the market of Ischemic Stroke Surgery

    Which region is predicted to have the largest market share of Ischemic Stroke Surgery

    North America is predicted to lead the market of Ischemic Stroke Surgery

    What are the key factors driving the market of Ischemic Stroke Surgery?

    Rise in physical inactivity and sedentary lifestyles and Adoption and launch of technologically advanced products are driving the market growth

    Which factors may act as market deterrents Ischemic Stroke Surgery?

    Lack of medical facilities and Shortage of skilled professionals are the market deterrents.

    1. EXECUTIVE SUMMARY
      1. 1.1
      2. OVERVIEW
      3. 2
    2. MARKET INTRODUCTION
      1. 2.1
      2. DEFINITION
      3. 2.2
      4. SCOPE OF THE STUDY
      5. 2.3
      6. RESEARCH OBJECTIVE
      7. 2.4
      8. MARKET STRUCTURE
      9. 2.5
      10. ASSUMPTIONS & LIMITATIONS
    3. RESEARCH METHODOLOGY
      1. DATA MINING
      2. SECONDARY RESEARCH
      3. PRIMARY RESEARCH
      4. BREAKDOWN OF PRIMARY RESPONDENTS
      5. FORECASTING TECHNIQUES
      6. RESEARCH METHODOLOGY
        1. BOTTOM-UP APPROACH
        2. TOP-DOWN APPROACH
      7. FOR MARKET SIZE ESTIMATION
      8. DATA TRIANGULATION
      9. VALIDATION
    4. MARKET DYNAMICS
      1. OVERVIEW
      2. DRIVERS
        1. RISE IN PHYSICAL INACTIVITY AND SEDENTARY LIFESTYLES
        2. ADOPTION AND LAUNCH
        3. RISING DEMAND FOR MINIMALLY INVASIVE PROCEDURES
      3. OF TECHNOLOGICALLY ADVANCED PRODUCTS
      4. RESTRAINTS
        1. LACK OF MEDICAL
      5. FACILITIES
      6. 4.3.2
      7. SHORTAGE OF SKILLED PROFESSIONALS
      8. OPPORTUNITIES
        1. R&D ACTIVITIES AND INVESTMENTS
    5. MARKET FACTOR ANALYSIS
      1. VALUE CHAIN ANALYSIS
        1. R&D
        2. MANUFACTURING
        3. DISTRIBUTION AND SALES
        4. POST-SALES MONITORING
      2. PORTER’S FIVE FORCES MODEL
        1. THREAT OF NEW ENTRANTS
        2. BARGAINING POWER
        3. INTENSITY OF RIVALRY
      3. OF SUPPLIERS
      4. 5.2.3
      5. THREAT OF SUBSTITUTES
      6. 5.2.4
      7. BARGAINING POWER OF BUYERS
      8. IMPACT OF COVID-19 ON THE GLOBAL ISCHEMIC STROKE SURGERY
      9. MARKET
      10. 5.3.1
      11. IMPACT ON SUPPLY CHAIN
      12. 5.3.2
      13. IMPACT ON PRODUCTION
      14. 5.3.3
      15. IMPACT ON DEMAND
      16. 5.4
    6. EPIDEMIOLOGY ANALYSIS
      1. 5.4.1
      2. INCIDENCE & PREVALENCE
    7. NUMBER OF PROCEDURES FOR THROMBECTOMY
      1. REGULATORY ANALYSIS/HEALTHCARE SYSTEM
    8. GLOBAL ISCHEMIC STROKE
    9. SURGERY MARKET, BY TYPE OF SURGERY
      1. OVERVIEW
      2. THROMBECTOMY
      3. REVASCULARIZATION SURGERY
      4. CAROTID ENDARTERECTOMY
      5. ANGIOPLASTY
      6. OTHERS
    10. GLOBAL ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT
      1. TYPE
      2. OVERVIEW
      3. CATHETER
      4. ASPIRATION SYSTEM
      5. GUIDEWIRE
      6. MICROCATHETER
      7. OTHERS
    11. GLOBAL ISCHEMIC STROKE
    12. SURGERY MARKET, BY END USER
      1. OVERVIEW
      2. HOSPITALS AND CLINICS
      3. AMBUATORY SURGICAL CENTRES
      4. OTHERS
    13. GLOBAL ISCHEMIC STROKE SURGERY MARKET, BY REGION
      1. OVERVIEW
      2. NORTH AMERICA
        1. US
        2. CANADA
      3. EUROPE
        1. GERMANY
        2. UK
        3. FRANCE
        4. ITALY
        5. SPAIN
        6. REST OF EUROPE
      4. ASIA PACIFIC
        1. JAPAN
        2. CHINA
        3. INDIA
        4. AUSTRALIA
        5. SOUTH KOREA
        6. REST OF ASIA PACIFIC
      5. REST OF THE WORLD
        1. MIDDLE EAST
        2. AFRICA
        3. LATIN AMERICA
    14. COMPETITIVE LANDSCAPE
      1. OVERVIEW
      2. MARKET SHARE ANAYISIS
      3. COMPETITIVE BENCHMARKING
      4. MAJOR GROWTH STRATEGY IN THE GLOBAL ISCHEMIC
    15. STROKE SURGERY MARKET
      1. 10.5
      2. THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL ISCHEMIC STROKE
    16. SURGERY MARKET
      1. 10.6
    17. KEY DEVELOPMENT ANALYSIS
      1. KEY DEVELOPMENTS & GROWTH STRATEGIES
        1. MERGER & ACQUISITIONS
        2. AGREEMENT/MARKETING STRATEGIES
      2. FINANCIAL MATRIX
        1. SALES (USD MILLION),
      3. 10.8.2
      4. RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2021
    18. COMPANY PROFILES
      1. MEDTRONIC PLC
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS OFFERED
        4. KEY DEVELOPMENTS
        5. SWOT ANALYSIS
        6. KEY STRATEGIES
      2. ABBOTT LABORATORIES
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS OFFERED
        4. KEY DEVELOPMENTS
        5. KEY STRATEGIES
      3. BOSTON SCIENTIFIC CORPORATION
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS OFFERED
        4. KEY DEVELOPMENTS
        5. KEY STRATEGIES
      4. CORDIS CORPORATION
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS OFFERED
        4. KEY DEVELOPMENTS
        5. KEY STRATEGIES
      5. KONINKLIJKE PHILIPS
      6. N.V
      7. 11.5.1
      8. COMPANY OVERVIEW
      9. 11.5.2
      10. FINANCIAL OVERVIEW
      11. 11.5.3
      12. PRODUCTS OFFERED
      13. 11.5.4
      14. KEY DEVELOPMENTS
      15. 11.5.5
    19. SWOT ANALYSIS
      1. 11.5.6
      2. KEY STRATEGIES
      3. 11.6
      4. STRYKER
      5. 11.6.1
      6. COMPANY OVERVIEW
      7. 11.6.2
      8. FINANCIAL OVERVIEW
      9. 11.6.3
      10. PRODUCTS OFFERED
      11. 11.6.4
      12. KEY DEVELOPMENTS
      13. 11.6.5
    20. SWOT ANALYSIS
      1. 11.6.6
      2. KEY STRATEGIES
      3. 11.7
      4. IMPERATIVE CARE
      5. 11.7.1
      6. COMPANY OVERVIEW
      7. 11.7.2
      8. FINANCIAL OVERVIEW
      9. 11.7.3
      10. PRODUCTS OFFERED
      11. 11.7.4
      12. KEY DEVELOPMENTS
      13. 11.7.5
      14. KEY STRATEGIES
      15. 11.8
      16. JOHNSON & JOHNSON SERVICES, INC.
    21. COMPANY OVERVIEWS
    22. FINANCIAL OVERVIEW
    23. PRODUCTS OFFERED
    24. KEY DEVELOPMENTS
    25. SWOT ANALYSIS
    26. KEY STRATEGIES
      1. PENUMBRA, INC.
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS OFFERED
        4. KEY DEVELOPMENTS
        5. SWOT ANALYSIS
        6. KEY STRATEGIES
      2. PHENOXYHENOX GMBH
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS OFFERED
        4. KEY DEVELOPMENTS
        5. KEY STRATEGIES
    27. APPENDIX
      1. REFERENCES
      2. RELATED REPORTS
    28. LIST OF TABLES
    29. LIST OF ASSUMPTIONS & LIMITATIONS
    30. PRIMARY INTERVIEWS
      1. AND INFORMATION GATHERING PROCESS
    31. NUMBER OF PROCEDURES FOR THROMBECTOMY, BY REGION (2021)
    32. NUMBER OF PROCEDURES
      1. FOR THROMBECTOMY, BY COUNTRY (2021)
    33. GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY TYPE
      1. OF SURGERY, 2018–2035 (USD MILLION)
    34. GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR
      1. THROMBECTOMY, BY REGION, 2018–2035 (USD MILLION)
    35. GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR
      1. REVASCULARIZATION SURGERY, BY REGION, 2018–2035 (USD MILLION)
    36. GLOBAL: ISCHEMIC STROKE
    37. SURGERY MARKET, FOR CAROTID ENDARTERECTOMY, BY REGION, 2018–2035 (USD MILLION)
    38. GLOBAL: ISCHEMIC
    39. STROKE SURGERY MARKET, FOR ANGIOPLASTY, BY REGION, 2018–2035 (USD MILLION)
    40. GLOBAL: ISCHEMIC
    41. STROKE SURGERY MARKET, FOR OTHERS, BY REGION, 2018–2035 (USD MILLION)
    42. GLOBAL: ISCHEMIC
    43. STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018–2035 (USD MILLION)
    44. GLOBAL: ISCHEMIC
    45. STROKE SURGERY MARKET, FOR CATHETER, BY REGION, 2018–2035 (USD MILLION)
    46. GLOBAL: ISCHEMIC
    47. STROKE SURGERY MARKET, FOR ASPIRATION SYSTEM, BY REGION, 2018–2035 (USD MILLION)
    48. GLOBAL: ISCHEMIC
    49. STROKE SURGERY MARKET, FOR GUIDEWIRE, BY REGION, 2018–2035 (USD MILLION)
    50. GLOBAL: ISCHEMIC
    51. STROKE SURGERY MARKET, FOR MICROCATHETER, BY REGION, 2018–2035 (USD MILLION)
    52. GLOBAL: ISCHEMIC
    53. STROKE SURGERY MARKET, FOR OTHERS, BY REGION, 2018–2035 (USD MILLION)
    54. GLOBAL: ISCHEMIC
    55. STROKE SURGERY MARKET, BY END USER, 2018–2035 (USD MILLION)
    56. GLOBAL: ISCHEMIC STROKE
    57. SURGERY MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2018–2035 (USD MILLION)
    58. GLOBAL: ISCHEMIC
    59. STROKE SURGERY MARKET, FOR AMBULATORY SURGERY CENTRES, BY REGION, 2018–2035
      1. (USD MILLION)
      2. TABLE
    60. GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR OTHERS BY REGION, 2018–2035
      1. (USD MILLION)
      2. TABLE
    61. GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY REGION, 2018–2035 (USD MILLION)
    62. NORTH AMERICA:
    63. ISCHEMIC STROKE SURGERY MARKET, BY COUNTRY, 2018–2035 (USD MILLION)
    64. NORTH AMERICA:
    65. ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
    66. NORTH AMERICA:
    67. ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018–2035 (USD MILLION)
    68. NORTH AMERICA:
    69. ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018–2035 (USD MILLION)
    70. US: ISCHEMIC
    71. STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
    72. US: ISCHEMIC
    73. STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018–2035 (USD MILLION)
    74. US: ISCHEMIC
    75. STROKE SURGERY MARKET, BY END USER, 2018–2035 (USD MILLION)
    76. CANADA: ISCHEMIC STROKE
    77. SURGERY MARKET, BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
    78. CANADA: ISCHEMIC STROKE
    79. SURGERY MARKET, BY PRODUCT TYPE, 2018–2035 (USD MILLION)
    80. CANADA: ISCHEMIC STROKE
    81. SURGERY MARKET, BY END USER, 2018–2035 (USD MILLION)
    82. EUROPE: ISCHEMIC STROKE SURGERY MARKET,
      1. BY COUNTRY, 2018–2035 (USD MILLION)
    83. EUROPE: ISCHEMIC STROKE SURGERY MARKET,
      1. BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
    84. EUROPE: ISCHEMIC STROKE SURGERY MARKET,
      1. BY PRODUCT TYPE, 2018–2035 (USD MILLION)
    85. EUROPE: ISCHEMIC STROKE SURGERY MARKET,
      1. BY END USER, 2018–2035 (USD MILLION)
    86. GERMANY: ISCHEMIC STROKE SURGERY MARKET,
      1. BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
    87. GERMANY: ISCHEMIC STROKE SURGERY MARKET,
      1. BY PRODUCT TYPE, 2018–2035 (USD MILLION)
    88. GERMANY: ISCHEMIC STROKE SURGERY MARKET,
      1. BY END USER, 2018–2035 (USD MILLION)
    89. UK: ISCHEMIC STROKE SURGERY MARKET, BY TYPE
      1. OF SURGERY, 2018–2035 (USD MILLION)
    90. UK: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT
      1. TYPE, 2018–2035 (USD MILLION)
    91. UK: ISCHEMIC STROKE SURGERY MARKET, BY END USER,
    92. FRANCE: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY,
    93. FRANCE: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018–2035
      1. (USD MILLION)
      2. TABLE
    94. FRANCE: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018–2035 (USD MILLION)
    95. ITALY: ISCHEMIC
    96. STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
    97. ITALY: ISCHEMIC
    98. STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018–2035 (USD MILLION)
    99. ITALY: ISCHEMIC
    100. STROKE SURGERY MARKET, BY END USER, 2018–2035 (USD MILLION)
    101. SPAIN: ISCHEMIC STROKE
    102. SURGERY MARKET, BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
    103. SPAIN: ISCHEMIC STROKE
    104. SURGERY MARKET, BY PRODUCT TYPE, 2018–2035 (USD MILLION)
    105. SPAIN: ISCHEMIC STROKE
    106. SURGERY MARKET, BY END USER, 2018–2035 (USD MILLION)
    107. REST OF EUROPE: ISCHEMIC STROKE SURGERY
    108. MARKET, BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
    109. REST OF EUROPE: ISCHEMIC STROKE SURGERY
    110. MARKET, BY PRODUCT TYPE, 2018–2035 (USD MILLION)
    111. REST OF EUROPE: ISCHEMIC STROKE SURGERY
    112. MARKET, BY END USER, 2018–2035 (USD MILLION)
    113. ASIA PACIFIC: ISCHEMIC STROKE SURGERY MARKET,
      1. BY COUNTRY, 2018-2035 (USD MILLION)
    114. ASIA-PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY
      1. TYPE OF SURGERY, 2018–2035 (USD MILLION)
    115. ASIA-PACIFIC: ISCHEMIC STROKE SURGERY MARKET,
      1. BY PRODUCT TYPE, 2018–2035 (USD MILLION)
    116. ASIA-PACIFIC: ISCHEMIC STROKE SURGERY MARKET,
      1. BY END USER, 2018–2035 (USD MILLION)
    117. JAPAN: ISCHEMIC STROKE SURGERY MARKET, BY
      1. TYPE OF SURGERY, 2018–2035 (USD MILLION)
    118. JAPAN: ISCHEMIC STROKE SURGERY MARKET, BY
      1. PRODUCT TYPE, 2018–2035 (USD MILLION)
    119. JAPAN: ISCHEMIC STROKE SURGERY MARKET, BY
      1. END USER, 2018–2035 (USD MILLION)
    120. CHINA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE
      1. OF SURGERY, 2018–2035 (USD MILLION)
    121. CHINA: ISCHEMIC STROKE SURGERY MARKET, BY
      1. PRODUCT TYPE, 2018–2035 (USD MILLION)
    122. CHINA: ISCHEMIC STROKE SURGERY MARKET, BY
      1. END USER, 2018–2035 (USD MILLION)
    123. INDIA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE
      1. OF SURGERY, 2018–2035 (USD MILLION)
    124. INDIA: ISCHEMIC STROKE SURGERY MARKET, BY
      1. PRODUCT TYPE, 2018–2035 (USD MILLION)
    125. INDIA: ISCHEMIC STROKE SURGERY MARKET, BY
      1. END USER, 2018–2035 (USD MILLION)
    126. AUSTRALIA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE
      1. OF SURGERY, 2018–2035 (USD MILLION)
    127. AUSTRALIA: ISCHEMIC STROKE SURGERY MARKET,
      1. BY PRODUCT TYPE, 2018–2035 (USD MILLION)
    128. AUSTRALIA: ISCHEMIC STROKE SURGERY MARKET,
      1. BY END USER, 2018–2035 (USD MILLION)
    129. SOUTH KOREA: ISCHEMIC STROKE SURGERY MARKET,
      1. BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
    130. SOUTH KOREA: ISCHEMIC STROKE SURGERY MARKET,
      1. BY PRODUCT TYPE, 2018–2035 (USD MILLION)
    131. SOUTH KOREA: ISCHEMIC STROKE SURGERY MARKET,
      1. BY END USER, 2018–2035 (USD MILLION)
    132. REST OF ASIA-PACIFIC: ISCHEMIC STROKE SURGERY
    133. MARKET, BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
    134. REST OF ASIA-PACIFIC: ISCHEMIC STROKE SURGERY
    135. MARKET, BY PRODUCT TYPE, 2018–2035 (USD MILLION)
    136. REST OF ASIA-PACIFIC: ISCHEMIC STROKE SURGERY
    137. MARKET, BY END USER, 2018–2035 (USD MILLION)
    138. REST OF THE WORLD: ISCHEMIC STROKE SURGERY
    139. MARKET, BY REGION, 2018-2035(USD MILLION)
    140. REST OF THE WORLD: ISCHEMIC STROKE SURGERY
    141. MARKET, BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
    142. REST OF THE WORLD: ISCHEMIC STROKE SURGERY
    143. MARKET, BY PRODUCT TYPE, 2018–2035 (USD MILLION)
    144. REST OF THE WORLD: ISCHEMIC STROKE SURGERY
    145. MARKET, BY END USER, 2018–2035 (USD MILLION)
    146. MIDDLE EAST: ISCHEMIC STROKE SURGERY MARKET,
      1. BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
    147. MIDDLE EAST: ISCHEMIC STROKE SURGERY MARKET,
      1. BY PRODUCT TYPE, 2018–2035 (USD MILLION)
    148. MIDDLE EAST: ISCHEMIC STROKE SURGERY MARKET,
      1. BY END USER, 2018–2035 (USD MILLION)
    149. AFRICA: ISCHEMIC STROKE SURGERY MARKET,
      1. BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
    150. AFRICA: ISCHEMIC STROKE SURGERY MARKET,
      1. BY PRODUCT TYPE, 2018–2035 (USD MILLION)
    151. AFRICA: ISCHEMIC STROKE SURGERY MARKET,
      1. BY END USER, 2018–2035 (USD MILLION)
    152. LATIN AMERICA: ISCHEMIC STROKE SURGERY MARKET,
      1. BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
    153. LATIN AMERICA: ISCHEMIC STROKE SURGERY MARKET,
      1. BY PRODUCT TYPE, 2018–2035 (USD MILLION)
    154. LATIN AMERICA: ISCHEMIC STROKE SURGERY MARKET,
      1. BY END USER, 2018–2035 (USD MILLION)
    155. MAJOR PLAYERS IN THE GLOBAL ISCHEMIC STROKE
    156. SURGERY MARKET
      1. TABLE
    157. MOST ACTIVE PLAYERS IN THE GLOBAL ISCHEMIC STROKE SURGERY MARKET
    158. PRODUCT LAUNCH/PRODUCT
      1. APPROVAL
      2. TABLE
    159. MERGER & ACQUISITIONS
    160. AGREEMENT/MARKETING STRATEGIES
    161. MEDTRONIC PLC: PRODUCTS OFFERED
    162. ABBOTT LABORATORIES:
      1. PRODUCTS OFFERED
      2. TABLE
    163. ABBOTT LABORATORIES: KEY DEVELOPMENTS
    164. BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
    165. CORDIS CORPORATION:
      1. PRODUCTS OFFERED
      2. TABLE
    166. KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED

    Ischemic Stroke Surgery Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials

    Compare Licence

    ×
    Features License Type
    Single User Multiuser License Enterprise User
    Price $4,950 $5,950 $7,250
    Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
    Free Customization
    Direct Access to Analyst
    Deliverable Format
    Platform Access
    Discount on Next Purchase 10% 15% 15%
    Printable Versions